Managing Patients With High-Risk Hepatocellular Carcinoma: Critical Considerations for the Interdisciplinary Team

Watch an on-demand webcast, download the slides, and read expert responses to questions from live events discussing current and emerging strategies in the management of early-stage, high-risk HCC.

Share

Program Content

Activities

Managing HCC
Managing HCC: Critical Considerations for the Interdisciplinary Team
Video
Congratulations: You achieved a completion on 04/09/2022

Released: February 15, 2024

Expires: February 14, 2025

Activities

Managing High-Risk HCC
Managing Patients With High-Risk Hepatocellular Carcinoma: Critical Considerations for the Interdisciplinary Team
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: January 30, 2024

Activities

Adj Immunotherapy for High-Risk HCC
Incorporating Adjuvant Immunotherapy Into the Treatment of Patients With High-Risk HCC
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: April 08, 2024

Expires: April 07, 2025

Faculty

cover img faculity

Thomas B. Karasic, MD

Physician Leader, Developmental Therapeutics
Assistant Professor of Medicine
Division of Hematology-Oncology
University of Pennsylvania
Philadelphia, Pennsylvania

cover img faculity

Amit Singal, MD, MS

Professor of Medicine
Medical Director of Liver Tumor Program
Chief of Hepatology
UT Southwestern Medical Center
Dallas, Texas

cover img faculity

Mark Yarchoan, MD

Associate Professor of Medical Oncology
Division of GI Malignancies
Sidney Kimmel Comprehensive Cancer Center
Johns Hopkins University
Baltimore, Maryland

Provided by

ProCE Banner

Provided by Clinical Care Options, LLC.

Supporters

Supported by an educational grant from Genentech, a member of the Roche Group.

Genentech, a member of the Roche Group